![](https://www.pharmatechoutlook.com/newstransfer/upload/450x308_05dz.webp)
Raising Capital For Early Stage Biotech Start-Ups
Raising money for early stage biotech companies, especially those that come out of universities and research organisations, is tough. And even when you do raise funds, the odds are stacked against you. Developing new drugs is a long hard road and there is …